The UK's health secretary, Andrew Lansley, is accepting proposals for a new regulatory body that would speed up applications by scientists carrying out health research, and open up the UK — to a greater degree — to drug companies wanting to carry out clinical trials, reports The Guardian's Sarah Boseley.
To read the full story....
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.